Cardio Diagnostics Holdings (CDIO) EBIT (QoQ) (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) EBIT (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - |
| 10 | Cardio Diagnostics Holdings | 6.10 Mn | 509,808.97 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.06% |
| Mar 31, 2026 | -21.98% |
| Dec 31, 2025 | 14.51% |
| Sep 30, 2025 | -1.96% |
| Jun 30, 2025 | -2.95% |
| Mar 31, 2025 | -7.53% |
| Dec 31, 2024 | -7.63% |
| Sep 30, 2024 | -9.86% |
| Jun 30, 2024 | 69.16% |
| Mar 31, 2024 | -169.65% |
| Dec 31, 2023 | -6.77% |
| Sep 30, 2023 | 43.43% |
| Jun 30, 2023 | -49.91% |
| Mar 31, 2023 | 28.38% |
| Dec 31, 2022 | -106.63% |
| Sep 30, 2022 | -46.24% |
| Jun 30, 2022 | -246.54% |
| Mar 31, 2022 | -56.27% |
| Dec 31, 2021 | -20,055.48% |
| Sep 30, 2021 | -81.61% |